US · Healthcare

Genscript Biotech Corporation (GNNSF)

Biotechnology

Genscript Biotech Corporation (GNNSF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GNNSF

P/E ratio

25.00

Genscript Biotech Corporation (GNNSF) — FAQ

What is GNNSF's P/E ratio?

The price-to-earnings (P/E) ratio for Genscript Biotech Corporation (GNNSF) is 25.00 (data as of 2026-05-23).

Does Genscript Biotech Corporation pay a dividend?

Dividend yield is not available in the current snapshot for Genscript Biotech Corporation (GNNSF). Check the MyAverix Finance app for the latest dividend data.

What sector is Genscript Biotech Corporation in?

Genscript Biotech Corporation (GNNSF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GNNSF listed on?

GNNSF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)